Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.1% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Immunic
IMUX
$191M
| $1.94M | ﹤0.01% |
15,993
+9,200
| +135% | +$936K |
|
|
SIOX
2202
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.93M | ﹤0.01% |
685,923
+217,800
| +47% | +$699K |
|
2203
Vanguard Dividend Appreciation ETF
VIG
$114B
| $1.93M | ﹤0.01% |
16,500
+7,000
| +74% | +$797K |
|
|
AT
2204
DELISTED
Atlantic Power Corporation
AT
| $1.93M | ﹤0.01% |
966,578
+723,024
| +297% | +$1.44M |
|
2205
Embotelladora Andina Series A
AKO.A
$3.67B
| $1.92M | ﹤0.01% |
156,600
+800
| +0.5% | +$9.29K |
|
2206
Ardmore Shipping
ASC
$690M
| $1.92M | ﹤0.01% |
442,522
-310,676
| -41% | -$1.66M |
|
2207
Alphatec Holdings
ATEC
$1.59B
| $1.92M | ﹤0.01% |
408,189
-132,390
| -24% | -$585K |
|
2208
CSP Inc
CSPI
$84M
| $1.92M | ﹤0.01% |
463,204
-25,630
| -5% | -$113K |
|
|
PROF
2209
Profound Medical
PROF
$304M
| $1.91M | ﹤0.01% |
112,880
-7,300
| -6% | -$92.1K |
|
2210
Diana Shipping
DSX
$311M
| $1.91M | ﹤0.01% |
1,820,545
-657,520
| -27% | -$754K |
|
2211
Transact Technologies
TACT
$57.6M
| $1.91M | ﹤0.01% |
416,897
-10,398
| -2% | -$43.6K |
|
|
CBL
2212
DELISTED
CBL& Associates Properties, Inc.
CBL
| $1.91M | ﹤0.01% |
7,000,284
+1,675,568
| +31% | +$445K |
|
2213
Aptevo Therapeutics
APVO
$5.1M
| – | – |
0
| – | – |
|
|
ATNX
2214
DELISTED
Athenex, Inc. Common Stock
ATNX
| $1.89M | ﹤0.01% |
+6,880
| New | +$1.46M |
|
2215
BRC Group Holdings
RILY
$308M
| $1.89M | ﹤0.01% |
86,839
-9,700
| -10% | -$186K |
|
|
GIFI
2216
DELISTED
Gulf Island Fabrication
GIFI
| $1.89M | ﹤0.01% |
615,013
+124,077
| +25% | +$372K |
|
2217
Standard Motor Products
SMP
$915M
| $1.89M | ﹤0.01% |
45,810
-16,490
| -26% | -$667K |
|
2218
Atlanticus Holdings
ATLC
$1.67B
| $1.88M | ﹤0.01% |
182,208
+13,600
| +8% | +$181K |
|
2219
Kingstone Companies
KINS
$294M
| $1.88M | ﹤0.01% |
425,889
+22,800
| +6% | +$108K |
|
2220
Amphenol
APH
$211B
| $1.88M | ﹤0.01% |
78,400
-1,696,000
| -96% | -$37.9M |
|
2221
Great Elm Group
GEG
$67.4M
| $1.88M | ﹤0.01% |
804,717
-1,100
| -0.1% | -$2.3K |
|
|
ADXS
2222
DELISTED
Advaxis Inc
ADXS
| $1.88M | ﹤0.01% |
3,498,918
-111,501
| -3% | -$74.9K |
|
2223
Tronox
TROX
$948M
| $1.87M | ﹤0.01% |
+258,600
| New | +$1.71M |
|
2224
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.23B
| $1.86M | ﹤0.01% |
+32,100
| New | +$1.82M |
|
2225
ACNB Corp
ACNB
$665M
| $1.85M | ﹤0.01% |
70,805
-20,105
| -22% | -$499K |
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.